Kent Lake Capital’s DarioHealth DRIO Stock Holding History

Kent Lake Capital’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-502	Closed	-$43K	–	40
2022 Q4	$43K	Buy	+502	New	+$45.2K	0.03%	38

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

YDMI

Y.D. More Investments Ramat Gan, Israel $2.55B AUM 104.35% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Kent Lake Capital's DRIO Position: Q1 2023 in Review

Kent Lake Capital sold out of DarioHealth (DRIO) in Q1 2023, closing a stake of 502 shares — an estimated $43K sold.

Kent Lake Capital first reported a position in DRIO in Q4 2022 and held it in 1 quarter. The position peaked at $43K in Q4 2022. 46 funds tracked by Wall St. Rank hold DRIO as of Q1 2023.

Kent Lake Capital reported no remaining DarioHealth position as of Q1 2023 after selling out during the quarter.
Kent Lake Capital sold 502 DarioHealth shares in Q1 2023, an estimated $43K.
Kent Lake Capital first reported a position in DarioHealth in Q4 2022 and held it in 1 quarter.
Kent Lake Capital's DarioHealth position peaked at $43K in Q4 2022.
46 funds tracked by Wall St. Rank held DarioHealth as of Q1 2023.

Based on Kent Lake Capital's 13F filing for Q1 2023, filed 15 May 2023.